Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
LITTLE ELM, Texas–(BUSINESS WIRE)–Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors... Read more.
Equity Bancshares, Inc. Will Announce First Quarter 2025 Results on April 15, 2025
WICHITA, Kan.–(BUSINESS WIRE)–Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its... Read more.
FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
– Qfitlia Becomes the Sixth Alnylam-Discovered RNAi Therapeutic Approved by U.S. FDA and First and Only to Treat Hemophilia A or B With or Without Inhibitors –... Read more.
BankUnited, Inc. to Announce First Quarter Results
MIAMI LAKES, Fla.–(BUSINESS WIRE)–BankUnited, Inc. (NYSE: BKU) announced today that financial results for the quarter ended March 31, 2025 will be made... Read more.
KB Home Announces the Grand Opening of Its Newest Community in Corona, California
Monteverdi offers personalized, new homes in the desirable Horsethief Canyon neighborhood with stunning mountain views and close to local schools, priced from the... Read more.
Aptiv to Release First Quarter 2025 Financial Results
SCHAFFHAUSEN, Switzerland–(BUSINESS WIRE)–Aptiv PLC (NYSE: APTV) will release its first quarter 2025 financial results on May 1, 2025 and will hold an... Read more.
Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy
The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Measuring AT activity levels helps people receive the appropriate dose,... Read more.
BNY Mellon Municipal Bond Closed-End Funds Declare Distributions
NEW YORK–(BUSINESS WIRE)–BNY Mellon Investment Adviser, Inc. announced today that BNY Mellon Municipal Income, Inc., BNY Mellon Strategic Municipal Bond... Read more.
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
SOMERVILLE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding written... Read more.
Pacific Coast Oil Trust Announces Monthly Net Profits Interest Calculations
HOUSTON–(BUSINESS WIRE)–PACIFIC COAST OIL TRUST (OTC–ROYTL) (the “Trust”), a royalty trust formed by Pacific Coast Energy Company LP (“PCEC”),... Read more.